Devon W. Edwards

Associate

New York
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
T 212 728 8650
F 212 728 9650
dedwardswillkie.com

Devon W. Edwards is an associate in the Intellectual Property Department. Devon’s practice focuses primarily on district court and appellate level patent litigation, as well as client counseling on intellectual property issues, including patent, copyright, trade secret, and trademark strategy, protection, and assertion.

Devon W. Edwards is an associate in the Intellectual Property Department. Devon’s practice focuses primarily on district court and appellate level patent litigation, as well as client counseling on intellectual property issues, including patent, copyright, trade secret, and trademark strategy, protection, and assertion.

Selected Significant Matters

  • Belcher v. Hospira (epinephrine) – Achieved judgment of non-infringement, invalidity, and unenforceability of asserted patent on behalf of Hospira in Hatch-Waxman litigation in District of Delaware.
  • Insurent Agency Corp. v. Hanover Insurance Co. – Achieved victory on summary judgment for Hanover on all claims in S.D.N.Y., including allegations of copyright infringement and trade secret misappropriation.
  • Merck v. Amneal (mometasone furoate) – Successfully defended district court judgment of non-infringement for Amneal at the Federal Circuit in appeal of Hatch-Waxman action.

Selected Professional and Business Activities

Devon is a member of the New York Intellectual Property Law Association.

Selected Publications and Lectures

  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, February 2021
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, November 2020
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2020
  • Willkie Obtains Significant Victory for Hospira in Pharmaceutical Patent Litigation, April 6, 2020
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, April 2020
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, January 2020
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2019
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2019
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, April 2019
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2018
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2018
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, January 2018
  • The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2017
  • Supreme Court Ruling in TC Heartland Revives Focus on the Corporate “Place of Business,” Willkie Client Memo (May 25, 2017)

Publications / News / Events

+ View All Publications / News / Events